Turnstone Biologics Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Turnstone Biologics Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q3 2024.
  • Turnstone Biologics Corp. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$17M, a 1.66% increase year-over-year.
  • Turnstone Biologics Corp. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$74.4M, a 42% decline year-over-year.
  • Turnstone Biologics Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$55.2M, a 79% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$74.4M -$17M +$287K +1.66% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$74.7M -$21.3M +$195K +0.91% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$74.9M -$19.6M -$19.7M -28966% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$55.2M -$16.5M -$2.78M -20.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$52.4M -$17.3M -$1.17M -7.23% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$51.2M -$21.5M -$33.1M -285% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$18.2M $68K +$12.7M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$30.8M -$13.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$16.2M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $11.6M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$12.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.